Plasma Transforming Growth Factor α and Amphiregulin Protein Levels in NCIC Clinical Trials Group BR.21Christina Addison, Penelope A. Bradbury, Glenwood D. Goss et al.|Journal of Clinical Oncology|2010Cited by 55
Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor TrialVered Stearns, Paul E. Goss, Judith‐Anne W. Chapman et al.|Journal of Clinical Oncology|2014Cited by 43